1. Home
  2. POLA vs SXTP Comparison

POLA vs SXTP Comparison

Compare POLA & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Polar Power Inc.

POLA

Polar Power Inc.

HOLD

Current Price

$1.74

Market Cap

4.7M

Sector

Miscellaneous

ML Signal

HOLD

Logo 60 Degrees Pharmaceuticals Inc.

SXTP

60 Degrees Pharmaceuticals Inc.

HOLD

Current Price

$1.73

Market Cap

4.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POLA
SXTP
Founded
1979
2010
Country
United States
United States
Employees
N/A
3
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7M
4.4M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
POLA
SXTP
Price
$1.74
$1.73
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$14.10
AVG Volume (30 Days)
84.9K
74.7K
Earning Date
04-15-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$24,801,141.00
N/A
Revenue This Year
N/A
$33.92
Revenue Next Year
N/A
$51.35
P/E Ratio
N/A
N/A
Revenue Growth
3.14
N/A
52 Week Low
$1.31
$0.34
52 Week High
$5.70
$8.62

Technical Indicators

Market Signals
Indicator
POLA
SXTP
Relative Strength Index (RSI) 44.00 61.17
Support Level $1.57 $1.29
Resistance Level $1.76 $1.82
Average True Range (ATR) 0.14 0.14
MACD -0.01 0.03
Stochastic Oscillator 19.52 68.39

Price Performance

Historical Comparison
POLA
SXTP

About POLA Polar Power Inc.

Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Asia, Europe and Middle East, United Kingdom, Other North America, South Africa, and others.

About SXTP 60 Degrees Pharmaceuticals Inc.

60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.

Share on Social Networks: